in the first quarter of 2023 wing relaunch of Wegovy OM TRx in the US 2 Novo Nordisk ® 131 109 14 Apr 2023 Wegovy ® AOM market The US • Commercial relaunch in January 2023 • Broad commercial formulary access • To safeguard continuity of care, the supply of the lower Wegovy ® dose strenghts in the US will be reduced temporarily International Operations • Wegovy ® launched in Denmark and Norway • Gradual roll-out in IO cations (includes Wegovy ® , Saxenda ® , Qsymia, Belviq and Contrave); CER: Constant exchange rates .
Download PDF file